Passa al contenuto
Merck

[Vasobral in the treatment of brain lesions: views of physicians and patients].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2013-03-27)
P R Kamchatnov
ABSTRACT

A study was based on the survey of 419 neurologists and 1189 their patients with different forms of cerebrovascular diseases using a specially developed questionnaire. In most cases, vasobral was used as a monotherapy or in a complex treatment. Twenty-two percent of physicians reported that vasobral was the most effective compared to other drugs. The good tolerability of treatment (18%) and the broad spectrum of indications and clinical effects (17%) were reported as well. The large percentage (75%) of patients indicated the positive effect of vasobral on memory, reasoning, vertigo etc The maximal effect was identified in the treatment of mild cognitive impairment caused by chronic brain ischemia and vertebrobasilar insufficiency. Vasobral is recommended for a use in a complex therapy in patients with more severe brain lesions and cognitive deficit.

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto

Supelco
Caffeina, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Caffeina, powder, ReagentPlus®
Sigma-Aldrich
Caffeina, anhydrous, 99%, FCC, FG
Supelco
Schmelzpunktstandard 235-237°C, analytical standard
Supelco
Caffeina, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
Caffeine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Caffeina, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
Sigma-Aldrich
Caffeina, Sigma Reference Standard, vial of 250 mg
Sigma-Aldrich
Caffeina, meets USP testing specifications, anhydrous
Supelco
Caffeine solution, analytical standard, 1.0 mg/mL in methanol
Supelco
Caffeina, traceable to primary standards (LGC)
Sigma-Aldrich
Caffeina, anhydrous, tested according to Ph. Eur.
Caffeina, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Caffeina, BioXtra
Caffeina, European Pharmacopoeia (EP) Reference Standard